WallStSmart

Nomura Holdings Inc ADR (NMR)vsPowell Max Limited Class A Ordinary Shares (PMAX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nomura Holdings Inc ADR generates 4892312% more annual revenue ($2.33T vs $47.65M). NMR leads profitability with a 17.3% profit margin vs -49.3%. NMR earns a higher WallStSmart Score of 84/100 (A-).

NMR

Exceptional Buy

84

out of 100

Grade: A-

Growth: 10.0Profit: 7.0Value: 7.0Quality: 3.0
Piotroski: 4/9Altman Z: 0.53

PMAX

Hold

49

out of 100

Grade: D+

Growth: 6.0Profit: 4.0Value: 5.0Quality: 6.0
Piotroski: 5/9Altman Z: -1.33

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NMR6 strengths · Avg: 9.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Operating MarginProfitability
30.8%10/10

Strong operational efficiency at 30.8%

Revenue GrowthGrowth
31.2%10/10

Revenue surging 31.2% year-over-year

PEG RatioValuation
0.828/10

Growing faster than its price suggests

P/E RatioValuation
12.8x8/10

Attractively priced relative to earnings

EPS GrowthGrowth
42.0%8/10

Earnings expanding 42.0% YoY

PMAX4 strengths · Avg: 9.8/10
Price/BookValuation
0.1x10/10

Reasonable price relative to book value

Operating MarginProfitability
34.3%10/10

Strong operational efficiency at 34.3%

Revenue GrowthGrowth
72.7%10/10

Revenue surging 72.7% year-over-year

Debt/EquityHealth
0.199/10

Conservative balance sheet, low leverage

Areas to Watch

NMR2 concerns · Avg: 1.5/10
Altman Z-ScoreHealth
0.532/10

Distress zone — elevated risk

Debt/EquityHealth
9.181/10

Elevated debt levels

PMAX4 concerns · Avg: 2.3/10
Market CapQuality
$1.58M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-167.3%2/10

ROE of -167.3% — below average capital efficiency

EPS GrowthGrowth
-78.7%2/10

Earnings declined 78.7%

Altman Z-ScoreHealth
-1.332/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : NMR

The strongest argument for NMR centers on Price/Book, Operating Margin, Revenue Growth. Profitability is solid with margins at 17.3% and operating margin at 30.8%. Revenue growth of 31.2% demonstrates continued momentum.

Bull Case : PMAX

The strongest argument for PMAX centers on Price/Book, Operating Margin, Revenue Growth. Revenue growth of 72.7% demonstrates continued momentum.

Bear Case : NMR

The primary concerns for NMR are Altman Z-Score, Debt/Equity. Debt-to-equity of 9.18 is elevated, increasing financial risk.

Bear Case : PMAX

The primary concerns for PMAX are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

NMR profiles as a growth stock while PMAX is a hypergrowth play — different risk/reward profiles.

PMAX carries more volatility with a beta of 2.15 — expect wider price swings.

PMAX is growing revenue faster at 72.7% — sustainability is the question.

Monitor CAPITAL MARKETS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NMR scores higher overall (84/100 vs 49/100), backed by strong 17.3% margins and 31.2% revenue growth. Both earn "Exceptional Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Nomura Holdings Inc ADR

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.

Powell Max Limited Class A Ordinary Shares

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Powell Max Limited Class A Ordinary Shares (PMAX) is an innovative technology firm focused on providing sustainable solutions that meet the needs of a rapidly changing market landscape. Supported by a seasoned management team and a strong financial position, PMAX is well-equipped to capitalize on emerging trends while effectively managing competitive challenges. The company’s dedication to innovation and operational excellence strengthens its diverse product portfolio and reinforces a customer-centric approach, generating lasting value. With strategic initiatives in place, PMAX is poised for a robust growth trajectory, making it an attractive investment opportunity for institutional stakeholders.

Visit Website →

Want to dig deeper into these stocks?